# Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.

> **NCT01549301** · PHASE1 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 128 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Filgrastim
- **DRUG:** Filgrastim
- **DRUG:** Filgrastim
- **DRUG:** Filgrastim

## Key facts

- **NCT ID:** NCT01549301
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549301, "Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01549301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
